Archives
-
What Fusion Tags Reveal in Functional Assays
2026-10-09
This Nature Chemistry study is useful as methods background, not as direct validation of a purification product. Compared with the parent Pum2–ELP behavior, adding GFP preserved concentration-dependent condensate formation. In Escherichia coli, mCherry–PRS produced more mCherry than mCherry mRNA without PRS at the late measured time point, whereas the same sequestration strategy reduced translation in protocells. The paper also documents IMAC and removable His6–SUMO processing, but does not compare tag performance, cleavage efficiency, yield, or recovery.
-
Affinity-Tag Handling in a PC4 Mechanistic Study
2026-10-07
Pan et al. describe an affinity-capture, Ulp1-mediated tag-processing, secondary cleanup, and size-exclusion design for recombinant PC4 used in cell-free interaction and methylation assays. The paper documents a sample-preparation strategy, not a comparison of affinity tags or proteases: it reports no yield, quantitative purity, or tagged-versus-cleaved performance data. The final tag composition also remains partly unclear because the methods describe His–GST-tagged material but specifically refer to removal of the His tag.
-
How Flag Capture Mapped WDFY1–Retromer Binding
2026-10-05
Chen et al. compared WDFY1-Flag affinity capture with anti-Flag beads alone, then used proteomics, co-immunoprecipitation and direct binding assays to evaluate candidate interactors. Retromer proteins VPS29, VPS26A, VPS26B and VPS35 were enriched in the WDFY1-Flag condition, while Vps29 or Vps35 knockdown versus control siRNA eliminated the reported WDFY1 effects on BMSC differentiation. This is a mechanistic case study, not a comparison of tag designs, elution chemistries, protease cleavage, or commercial purification products.
-
Affinity Tags in Recombinant Lipase Workflows
2026-10-02
This review supports a division of labor rather than a universal best tag: MBP and SUMO are presented as solubility or folding partners, whereas His-tag and GST are presented as affinity handles for IMAC or glutathione-resin purification. TEV- and Factor Xa-recognition linkers are discussed as options for post-purification tag removal, while the reviewed immobilization examples report complete specific activity for a CALB–cellulose-binding-domain fusion after immobilization and 90% activity recovery with a Sil3K-tagged lipase A; these are distinct systems, not head-to-head comparisons.
-
His6 and SUMO Tags in Me-FDH1 Purification
2026-09-30
Nguyen et al. show that a C-terminal His6 tag on the Me-FDH1 α-subunit enabled Ni-NTA enrichment of the associated β-subunit compared with crude-cell-extract detection, but the study did not show that His6 increased expression or catalytic quality. In E. coli K-12 Shuffle T7, SUMO constructs produced no detectable increase in α-subunit accumulation, and the best SUMO-associated preparations showed only about 3.1–4.0 U mg−1, below the approximately 8.0–8.2 U mg−1 reported for the EcK/pCM2 benchmark; because these tests used different host and plasmid contexts, this was not a clean tag-only comparison. The results place the main limitation after translation, where α-subunit maturation or stability—not affinity capture alone—constrains recovery of active enzyme.
-
Cas13d Purification for Light-Controlled RNA Assays
2026-09-28
This study engineered stimulus-responsive RfxCas13d variants and used purified protein in supporting biochemical assays. Its methods describe a 6×His/TEV-site construct, Ni-IMAC, and subsequent cation-exchange chromatography; they do not report TEV cleavage or compare purification strategies.
-
Baicalin and Adult Cortical Plasticity: Assay Lessons
2026-09-24
Baicalin reactivated ocular dominance plasticity in an adult mouse amblyopia model, offering a useful case study in how to connect neural activity, inhibitory markers, and functional recovery. This article examines the study’s experimental logic, its limits, and practical considerations for research use.
-
Oleanolic Acid: From Liposome Metrics to Biology
2026-09-23
Oleanolic acid research depends on more than measuring how much compound enters a liposome. This article explains how to interpret encapsulation data, choose fit-for-purpose analytical methods, and connect delivery measurements cautiously to immune and antiviral research.
-
BI-1347 Inhibitor: CDK8/19 Translation
2026-09-23
BI-1347 offers translational researchers a selective small-molecule starting point for testing target-dependent signaling and antitumor biology. This article connects its research-use profile with a 2026 Bone Research study of CDK8/19 inhibition in osteoarthritis, while distinguishing study-derived evidence from product specifications and proposed workflows.
-
3X FLAG Peptide for Mechanistic Protein Assays
2026-09-22
The 3X (DYKDDDDK) Peptide can do more than improve signal: it helps connect protein recovery, immunodetection, and structural validation in mechanistic workflows. This guide integrates FLAG assay design with lessons from nimbolide chemoproteomics and provides practical controls for metal-sensitive experiments.
-
Cerulenin Reveals How Leucomycin Is Biosynthesized
2026-09-21
The 1977 study by Takeshima, Kitao, and Omura used cerulenin to show that Leucomycin biosynthesis in Streptomyces kitasatoensis depends on a fatty-acid-like condensation process. Its combination of reversible inhibition, radiolabeled acetate tracing, and macromolecular synthesis controls provided early functional evidence for a polyketide origin of the macrolide aglycone.
-
FLAG tag Peptide: From Purification to Mechanism
2026-09-21
A translational guide to using the FLAG tag Peptide (DYKDDDDK) as more than a detection reagent: a controllable bridge between recombinant protein production, biochemical validation, and mechanistic interpretation.
-
EZH2 Inhibition Restrains SAHA-Induced SASP in SCLC
2026-09-18
The Cell Death Discovery study links SAHA-induced senescence in small cell lung cancer cells to cytoplasmic chromatin fragments, Tpr-dependent nuclear changes, and cGAS-STING activation. Its central advance is showing that EZH2 inhibition can reduce this inflammatory secretory program while strengthening SAHA-mediated growth suppression, suggesting a strategy to separate therapeutic senescence from tumor-promoting SASP.
-
Aminopeptidase Inhibitors in Cancer Therapy
2026-09-18
Hitzerd and colleagues position aminopeptidases as actionable nodes downstream of the ubiquitin–proteasome system and explain why their inhibitors may complement anticancer treatment. The review’s main practical contribution is a framework linking enzyme localization, substrate processing, inhibitor exposure, combination therapy, and resistance biology rather than treating aminopeptidase inhibition as a single-target strategy.
-
Nitrocefin Workflows for β-Lactamase Assays
2026-09-17
Nitrocefin converts β-lactamase activity into a rapid yellow-to-red signal, making it useful for resistance profiling, enzyme kinetics, and inhibitor screening. This workflow connects practical assay design with the peptide-discovery strategy reported for TEM-1 β-lactamase, helping researchers move computational hits toward experimental validation.